Can price controls reduce pharmaceutical expenses? A case study of antibacterial expenditures in 12 Chinese hospitals from 1996 to 2005.

Han, Sheng; Liang, Huigang; Su, Weiping; Xue, Yajiong; Shi, Luwen

Han, Sheng; Liang, Huigang; Su, Weiping; Xue, Yajiong; Shi, Luwen.

Affiliation

Han S; School of Pharmaceutical Science, Peking University Health Science Center, Beijing, China.

Int J Health Serv ; 43(1): 91-103, 2013.

Article in En | MEDLINE | ID: mdl-23527456

Subject(s)

Anti-Bacterial Agents/economics; Drug Costs/standards; Inappropriate Prescribing/economics; Pharmacy Service, Hospital/economics; China; Cost Control/legislation & jurisprudence; Cost Control/methods; Drug Costs/legislation & jurisprudence; Drug Costs/trends; Financing, Government/legislation & jurisprudence; Financing, Government/standards; Financing, Government/trends; Government Regulation; Health Expenditures; Health Policy/economics; Health Policy/legislation & jurisprudence; Health Policy/trends; Humans; Inappropriate Prescribing/legislation & jurisprudence; Inappropriate Prescribing/trends; Pharmacy Service, Hospital/legislation & jurisprudence; Pharmacy Service, Hospital/standards

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pharmacy Service, Hospital / Drug Costs / Inappropriate Prescribing / Anti-Bacterial Agents Type of study: Health_economic_evaluation / Prognostic_studies Limits: Humans Country/Region as subject: Asia Language: En Journal: Int J Health Serv Year: 2013 Type: Article Affiliation country: China

Search on Google

XML

PubMed Links